Skip to Content

Tian'an Pharmaceutical Co Ltd TNPH

Morningstar Rating
$0.01 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TNPH is trading at a 818% premium.
Price
$0.01
Fair Value
$2.34
Uncertainty
Extreme
1-Star Price
$8.91
5-Star Price
$5.37
Economic Moat
Bfnjg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TNPH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.000.04
Bid/Ask
$0.01 / $0.01
Market Cap
$92,366.01
Volume/Avg
800 / 3,640

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tian'an Pharmaceutical Co Ltd is engaged in investing, advising and building businesses in the sustainability sector, including in the health and wellness, education, sustainability, food and agriculture, fintech, e-commerce, tourism and consumer sectors.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
126
Website

Valuation

Metric
TNPH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TNPH
Quick Ratio
13.28
Current Ratio
14.23
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
TNPH
Return on Assets (Normalized)
23.83%
Return on Equity (Normalized)
25.27%
Return on Invested Capital (Normalized)
25.07%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRLkfmhzfnzyYrrnl$78.2 Bil
ZTS
Zoetis Inc Class ANcltnqxwhdGxdfc$78.0 Bil
HLN
Haleon PLC ADRCjrjcmmgWhzb$37.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRWsnztfwdWghpd$19.1 Bil
VTRS
Viatris IncXkwyczclHbsz$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKktdkmzwpGcvd$11.8 Bil
CTLT
Catalent IncSqgrvmxyTqsldv$9.9 Bil
PRGO
Perrigo Co PLCXkxxglkZnn$3.8 Bil
CURLF
Curaleaf Holdings IncLzcplksQyhv$3.5 Bil
PBH
Prestige Consumer Healthcare IncTcsfmfjycNqvtqn$3.2 Bil

Sponsor Center